美德醫療-DR 9103.TW Value Analysis
TW StockBiotech. & Medical
(No presentation for 9103)
9103
美德醫療-DR
5.02D
-1.18%
(-0.06)
9103 Value Score
3
24
15
Limited Growth
- AI analysis rates 9103 with a lower value score of 2.
- It is mainly due to unstable operating cash flow, along with lower ROE.
- Over the past 3 months, 9103 has maintained a consecutive value rating of 2.0, slightly lower than the rating of 3.4 over the past 3 years, indicating slight decrease in enterprise value.
- Compared to all stocks in the Biotech. & Medical sector, 9103 has a medium value rating.
9103 Value Reference Factors
The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.
Update to 2025/04/18 (Weekly Update)
9103 Financial Forecast
Unit : TWD
Update to 2025/5/9 (Quarterly Update)
9103 Earnings Table
No related data records
9103 Historical Value Score
You can use historical scores of 3 or above to observe potential performance and make investment decisions.
9103 Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of 9103 from 2007/01 till Now
- 194.40%
- Cumulative Return
- 6.23%
- Annual Return
- 39.38%
- Volatility
- 0.16
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from January, 2007 to May, 2025. (Total Trades: 1)
| 9103 | Sector | TW Overall Market | |
|---|---|---|---|
| Wining Rate | 100% | 46% | 53% |
| Avg Return | 197.4% | 21.1% | 45.4% |
| Avg Profit | 197.4% | 72.2% | 102.9% |
| Avg Loss | - | -22.4% | -20.3% |
| Avg Risk-Reward Ratio | - | 322.8% | 505.8% |
Update to 2025/5/10 (Daily Update)